Trevi Therapeutics annual meeting results: all director nominees elected, auditor ratified

Trevi Therapeutics, Inc.

Dominick Colangelo re-elected as Class II director with 47.1M votes for (99.8% of votes cast).
Edward Mathers re-elected with 32.7M for; David Meeker re-elected with 33.6M for.
Ernst & Young ratified as independent auditor for FY2024 with 54.0M for (99.9% of votes cast).

item 5.07

Trevi Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-073129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.